Gary Sender is listed as a director on 5 SEC Form D filings by 1 issuer between Apr 2025 and Mar 2026: Apnimed, Inc. (Cambridge, MA — pharmaceuticals — 2025–2026; $79.7M reported sold to 14 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Barry Wohl (5 shared filings), Chris Dimitropoulos (5 shared filings), Dennis Molnar (5 shared filings), Francois Beaubien (5 shared filings), Isaac Cheng (5 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gary. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Gary Sender and found 5 differences: Form D filed 16 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.